BREA,
Calif., Nov. 20, 2024 /PRNewswire/ -- Envista
Holdings Corporation (NYSE: NVST) today announced the release of
its 2023 Sustainability Report, outlining its continued efforts to
integrate environmental, social, and governance (ESG)
considerations into its mission to digitize, personalize, and
democratize dental care. The full report can be found HERE.
"Our efforts to promote improved environment, social, and
governance initiatives are central to how we support our
stakeholders. Through the lens of our key areas of focus –
Delivering Quality and Access; Supporting Our People and Community;
Safeguarding the Environment; Centering Ethics and Compliance; and
Practicing Good Governance – we have maintained steady progress in
finding ways to improve how we work," said Paul Keel, CEO of Envista. "As we release
our fourth annual sustainability report, it is a pleasure to share
the many ways in which we have delivered improved sustainability
outcomes across our business."
Selected Highlights from Envista's 2023 Sustainability
Report:
- Realized a 26% year-over-year reduction in our absolute Scope 1
greenhouse gas emissions and a 3.5% reduction of total (Scope 1 and
2) greenhouse gas emissions on an intensity basis.
- Donated nearly $1.3 million to
support mission trips, education opportunities, and direct
donations to oral health-focused non-profit organizations through
the Envista Smile Project.
- Invested in several Kaizen projects to meaningfully enhance
sustainability and operational efficiency on waste generation and
energy use at several facilities.
- Continued to achieve both 99% gender pay equity and 99% ethnic
pay equity in the U.S.
Mr. Keel continued, "We are proud of our long track record of
sustainability, and we are pleased with our further progress this
year. As we look ahead to address the challenges of tomorrow, we
remain energized to continue supporting our people, our customers,
and our shareholders."
The 2023 Sustainability Report provides both Envista's
sustainability-related performance to date and the foundation upon
which Envista will continue to identify opportunities for
continuous improvement across the Company's key sustainability
topics. The Company welcomes all stakeholder feedback on its 2023
Sustainability Report, which can be shared via email at
sustainability@envistaco.com.
ABOUT ENVISTA HOLDINGS CORPORATION
Envista is a global family of more than 30 trusted dental
brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by
a shared purpose: to partner with professionals to improve lives.
Envista helps its customers deliver the best possible patient care
through industry-leading dental consumables, solutions, technology,
and services. Its comprehensive portfolio, including dental
implants and treatment options, orthodontics, and digital imaging
technologies, covers a wide range of dentists' clinical needs for
diagnosing, treating, and preventing dental conditions as well as
improving the aesthetics of the human smile. With a foundation
comprised of the proven Envista Business System (EBS) methodology,
an experienced leadership team, and a strong culture grounded in
continuous improvement, commitment to innovation, and deep customer
focus, Envista is well equipped to meet the end-to-end needs of
dental professionals worldwide. Envista is one of the largest
global dental products companies, with significant market positions
in some of the most attractive segments of the dental products
industry. For more information, please visit www.envistaco.com.
FORWARD-LOOKING STATEMENTS
Certain statements in this press release are "forward-looking"
statements within the meaning of the federal securities laws. There
are a number of important factors that could cause actual results,
developments and business decisions to differ materially from those
suggested or indicated by such forward-looking statements and you
should not place undue reliance on any such forward-looking
statements. These factors include, among other things, the
conditions in the U.S. and global economy, the impact of inflation
and increasing interest rates, international economic, political,
legal, compliance and business factors, the markets served by us
and the financial markets, the impact of our debt obligations on
our operations and liquidity, developments and uncertainties in
trade policies and regulations, contractions or growth rates and
cyclicality of markets we serve, risks relating to product
manufacturing, commodity costs and surcharges, our ability to
adjust purchases and manufacturing capacity to reflect market
conditions, reliance on sole or limited sources of supply,
disruptions relating to war, terrorism, climate change, widespread
protests and civil unrest, man-made and natural disasters, public
health issues and other events, security breaches or other
disruptions of our information technology systems or violations of
data privacy laws, security breaches or other disruptions affecting
our external information technology contractors, vendors or other
service providers, fluctuations in inventory of our distributors
and customers, loss of a key distributor, our relationships with
and the performance of our channel partners, competition, our
ability to develop and successfully market new products and
services, our ability to attract, develop and retain our key
personnel, the potential for improper conduct by our employees,
agents or business partners, our compliance with applicable laws
and regulations (including regulations relating to medical devices
and the health care industry), the results of our clinical trials
and perceptions thereof, penalties associated with any off-label
marketing of our products, modifications to our products that
require new marketing clearances or authorizations, our ability to
effectively address cost reductions and other changes in the health
care industry, our ability to successfully identify and consummate
appropriate acquisitions and strategic investments, our ability to
integrate the businesses we acquire and achieve the anticipated
benefits of such acquisitions, contingent liabilities relating to
acquisitions, investments and divestitures, our ability to
adequately protect our intellectual property, the impact of our
restructuring activities on our ability to grow, risks relating to
impairment charges for our goodwill and intangible assets, changes
in accounting standards and subjective assumptions, estimates and
judgment by management, currency exchange rates, changes in tax
laws applicable to multinational companies, litigation and other
contingent liabilities including intellectual property and
environmental, health and safety matters, risks relating to
product, service or software defects, the impact of regulation on
demand for our products and services, and labor matters. Additional
information regarding the factors that may cause actual results to
differ materially from these forward-looking statements is
available in our SEC filings, including our Annual Report on Form
10-K for fiscal year 2023 and our Quarterly reports on Form 10-Q.
These forward-looking statements speak only as of the date of this
press release and except to the extent required by applicable law,
we do not assume any obligation to update or revise any
forward-looking statement, whether as a result of new information,
future events and developments or otherwise.
CONTACT
Melissa Morrison
Envista Holdings Corporation
200 S. Kraemer Blvd., Building E
Brea, California 92821
Telephone: (714) 817-7000
View original content to download
multimedia:https://www.prnewswire.com/news-releases/envista-announces-release-of-2023-sustainability-report-302312097.html
SOURCE Envista Holdings Corporation